Furthermore, ACSL4 modulation via deubiquitination has been demonstrated to promote HCC by influencing FA biosynthesis, lipid peroxidation, and the tumor immune microenvironment [119]. This evidence concerns the gene ACSL4 and hepatocellular carcinoma.